De Backer Marianne 4
4 · Vir Biotechnology, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
De Backer Marianne
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-02-24$9.45/sh−16,122$152,408→ 849,217 total - Award
Stock Option (Right to Buy)
2025-02-22+480,000→ 480,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (480,000 underlying) - Award
Common Stock
2025-02-22+240,000→ 865,339 total
Holdings
- 53,118(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees.
- [F4]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.